Doxepin Hcl
Brand name: Doxepin Hcl
Rank #402 of 500 drugs by total cost
$22.2M
Total Cost
371,255
Total Claims
$22.2M
Total Cost
13,829
Prescribers
$60
Cost per Claim
31,717
Beneficiaries
505,545
30-Day Fills
$1,602
Avg Cost/Provider
27
Avg Claims/Provider
About Doxepin Hcl
Doxepin Hcl (sold as Doxepin Hcl) was prescribed 371,255 times by 13,829 Medicare Part D providers in 2023, costing the program $22.2M. At $60 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology